Skip to main content

Diagnostics Growth Hub

MedCity has convened a range of world-leading organisations to form the Diagnostics Growth Hub, a ‘one stop shop’ for diagnostics companies to be able to access all the support they need to flourish.

Register your interest now


We are catalysing the development of novel diagnostic technologies by connecting innovative companies with expertise from the London health and life sciences ecosystem.

We support companies with their diagnostic development, evaluation, validation and implementation to place London and the UK as leaders in diagnostic development and scale. The Hub is a ‘one stop shop’ for companies to access support and guidance on a range of areas including R&D, clinical trials, manufacturing, funding and regulatory issues.

Read our interview with Prof George Hanna and Neelam Patel

Why Diagnostics?

The COVID-19 pandemic provided evidence of the importance of diagnostics. MedCity set up the London Testing Alliance and found that by bringing together London’s academic institutions, along with the private laboratories that served hospitals, we were able to create capacity for over 20,000 PCR tests per day.

The project brought together huge capability and expertise, and formed a unit that operationalised a huge task in an effective way. We recognised that this spirit of collaboration and capability should be ‘business as usual’ in how our ecosystem operates and we aim to harness this to meet the demands from the diagnostics industry.

Hub Partners

We have brought together expertise and knowledge from across academic institutions and non-profits including Queen Mary University of London, Imperial College London, King’s College London, University College London, Asthma UK and the British Lung Foundation Partnership, Health Services Laboratories, NIHR London In Vitro Diagnostics Cooperative and NIHR Clinical Research Network North West London.

The Hub offers bespoke support drawing on these world-leading partner organisations, recognised for their excellence in academic and clinical research and evaluation, and commercial experience, alongside representation from patients and the public.


Find out more about our partners & capabilities

Access the Hub expertise

National and international companies that are developing diagnostics products including Point of Care, In vivo diagnostics, In vitro diagnostics and imaging, looking for support and guidance, should fill in our short form. Whether you work in oncology, respiratory, infectious diseases, or another therapeutic area, we can connect you with the expertise to support you on your innovation journey towards commercialisation.

We aim to provide bespoke support around R&D, clinical trials, manufacturing, funding, regulatory issues, and much more. Please fill in this form with as much detail as possible and we will connect you with the right person for your needs.

Complete an access request

The UK has all the components to be truly world-leading in diagnostics. We have one solid organisational structure in the NHS and some of the best minds in academia and patient care. We just need these to be aligned.

Professor George Hanna
Clinical Lead, NIHR London In Vitro Diagnostics Co-operative

Collaborate to Innovate London Diagnostics

Our new Collaborate to Innovate programme is supporting collaborations between diagnostics SMEs and commercial partners, academic research groups, medical research charities and the NHS. With up to £100k in grant funding for each of the 10 collaborative projects, the SMEs will tap into the knowledge and expertise of partners with the aim of commercialising innovations and improving health outcomes for Londoners.


Contact us